Search results for: Baylor Scott & White Medical Center – Temple

Discovery of functional binding protein for salinomycin could open new research in targeting neuroblastoma stem cells

The American Cancer Society identifies neuroblastoma as “by far the most common cancer in infants (less than 1-year-old).” According to the latest statistics, neuroblastoma accounts for about 6 percent of all cancers in children, with an estimated 800 new cases identified each year in the United States.

Read more

Enrollment opens in Temple and Round Rock for Phase III PSVT trial conducted in an outpatient setting

Baylor Scott & White Medical Centers in Temple and Round Rock have opened enrollment on a study examining the safety and efficacy of Etripamil Nasal Spray in terminating paroxysmal supraventricular tachycardia (PSVT). These locations represent two of just four sites across the entire state of Texas that were awarded the trial.

Read more